Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSR
2176
Centerspace
CSR
$921M
| $11.3M | ﹤0.01% |
206,917
+8,016
| +4% | +$494K |
|
|
IAS
2177
DELISTED
Integral Ad Science
IAS
| $11.3M | ﹤0.01% |
790,555
+409,401
| +107% | +$4.6M |
|
|
UMH
2178
UMH Properties
UMH
$1.29B
| $11.2M | ﹤0.01% |
758,463
+67,731
| +10% | +$1.11M |
|
2179
Levi Strauss
LEVI
$9.44B
| $11.2M | ﹤0.01% |
615,228
+14,791
| +2% | +$254K |
|
|
HDSN
2180
Hudson Technologies
HDSN
$254M
| $11.2M | ﹤0.01% |
1,278,791
+173,622
| +16% | +$1.68M |
|
2181
Aldeyra Therapeutics
ALDX
$92.9M
| $11.1M | ﹤0.01% |
1,122,908
+232,676
| +26% | +$1.64M |
|
|
RPT
2182
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $11.1M | ﹤0.01% |
1,168,125
+52,172
| +5% | +$525K |
|
2183
FS Bancorp
FSBW
$319M
| $11.1M | ﹤0.01% |
369,769
+2,411
| +0.7% | +$81.4K |
|
2184
Amtech Systems
ASYS
$268M
| $11M | ﹤0.01% |
1,156,382
+8,268
| +0.7% | +$77.7K |
|
2185
Gulfport Energy Corp
GPOR
$2.9B
| $11M | ﹤0.01% |
137,857
+28,359
| +26% | +$2.06M |
|
2186
DigitalOcean
DOCN
$13.7B
| $11M | ﹤0.01% |
281,262
+173,960
| +162% | +$5.47M |
|
2187
InterContinental Hotels
IHG
$23.9B
| $11M | ﹤0.01% |
165,105
+5,343
| +3% | +$361K |
|
2188
Lands' End
LE
$370M
| $11M | ﹤0.01% |
1,130,930
+28,080
| +3% | +$235K |
|
2189
Alico
ALCO
$280M
| $11M | ﹤0.01% |
454,170
+17,200
| +4% | +$441K |
|
2190
Castle Biosciences
CSTL
$855M
| $11M | ﹤0.01% |
483,652
+159,966
| +49% | +$3.91M |
|
2191
Citi Trends
CTRN
$555M
| $11M | ﹤0.01% |
576,916
+78,635
| +16% | +$2.16M |
|
|
IVAC
2192
DELISTED
Intevac Inc
IVAC
| $11M | ﹤0.01% |
1,496,324
+96,436
| +7% | +$678K |
|
2193
Vital Farms
VITL
$545M
| $11M | ﹤0.01% |
715,767
+238,912
| +50% | +$3.78M |
|
2194
Gencor Industries
GENC
$209M
| $10.9M | ﹤0.01% |
730,697
+11,073
| +2% | +$139K |
|
2195
Southern Missouri Bancorp
SMBC
$852M
| $10.9M | ﹤0.01% |
292,434
+15,632
| +6% | +$703K |
|
|
CATC
2196
DELISTED
CAMBRIDGE BANCORP
CATC
| $10.9M | ﹤0.01% |
168,756
+56,508
| +50% | +$4.37M |
|
2197
Anterix
ATEX
$1.81B
| $10.9M | ﹤0.01% |
330,935
+40,061
| +14% | +$1.31M |
|
|
CFB
2198
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $10.9M | ﹤0.01% |
1,041,813
+134,333
| +15% | +$1.72M |
|
2199
Northern Oil and Gas
NOG
$2.3B
| $10.9M | ﹤0.01% |
358,533
-22,457
| -6% | -$700K |
|
|
AKRO
2200
DELISTED
Akero Therapeutics
AKRO
| $10.8M | ﹤0.01% |
283,516
-7,090
| -2% | -$316K |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.